Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bellus Health Inc (BLU)

Bellus Health Inc (BLU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,599.000 (-1.17%)
GSK : 40.48 (-0.69%)
BLU.TO : 19.48 (-0.10%)
BELLUS Health Announces Meeting Updates

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...

BLU : 14.74 (unch)
BLU.TO : 19.48 (-0.10%)
3 Biotechs That Might Get Bought Out in 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
MRK : 130.72 (+0.81%)
PFE : 27.74 (unch)
GSK : 40.48 (-0.69%)
MDGL : 278.42 (+3.97%)
AMLX : 1.7800 (+7.88%)
AUPH : 5.53 (+1.28%)
Was This Acquisition a Savvy Play by This Big Pharma Stock?

The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.

GSK : 40.48 (-0.69%)
BLU : 14.74 (unch)
MRK : 130.72 (+0.81%)
Moore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

BLU : 14.74 (unch)
STSA : 1.1000 (-0.90%)
RXDX : 199.92 (+0.09%)
Why This Nasdaq Stock Caught Fire This Week

A wave of bargain buying benefited the gene therapy company's shares this week.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
TNYA : 3.12 (-2.19%)
Why Shares of Bellus Health Skyrocketed This Week

The company has received a buyout offer from GSK.

BLU : 14.74 (unch)
GSK : 40.48 (-0.69%)
MRK : 130.72 (+0.81%)
Stocks Close Slightly Higher Despite Bank Stock Weakness and Hawkish Fed Comments

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 5,464.62 (-0.16%)
SPY : 544.51 (-0.13%)
$DOWI : 39,150.33 (+0.04%)
DIA : 391.34 (+0.04%)
$IUXX : 19,700.43 (-0.26%)
QQQ : 480.18 (-0.27%)
PHM : 111.57 (+0.80%)
LEN : 151.55 (+1.50%)
DHI : 142.39 (+0.88%)
TOL : 117.12 (+1.24%)
TYL : 489.14 (+2.11%)
NVDA : 126.57 (-3.22%)
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical...

BLU : 14.74 (unch)
GSK : 40.48 (-0.69%)
GSK.LN : 1,599.000 (-1.17%)
BLU.TO : 19.48 (-0.10%)
Why BELLUS Health Stock Is Rocketing Higher Today

A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.

RXDX : 199.92 (+0.09%)
BLU : 14.74 (unch)
GSK : 40.48 (-0.69%)
MRK : 130.72 (+0.81%)

Barchart Exclusives

GDP, Fed Speakers and Other Key Things to Watch this Week
This coming week is pretty news-heavy with PCE and GDP all due out. In addition, there are several fed speakers at some odd times which can cause some volatility in the market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar